Stephanie L. Silveria

机构：Molecular Sciences Institute, University of California, Berkeley · ORCID：0000-0001-5278-6939

发表论文 16 篇 · 总被引 1024 次 · h-index 6

代表论文

• Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes (2018 · Science · 被引 389)
• Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity (2018 · Cell Reports · 被引 323)
• A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism (2018 · Nature Medicine · 被引 201)
• Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy (2018 · The Journal of Immunology · 被引 66)
• Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation (2024 · Cell Reports · 被引 28)
• Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity (2026 · Science Advances · 被引 10)